1.Usefulness of glomerular filtration rate using 31Cr-EDTA clearance to evaluate glomerular hyperfiltration.
Soon Bae KIM ; Kang Hyun CHOI ; Su Kil PARK ; Dae Hyuk MOON ; Myoung Hae LEE ; Ki Up LEE ; Jung Sik PARK ; Changgi D HONG
Korean Journal of Nephrology 1991;10(4):486-491
No abstract available.
Glomerular Filtration Rate*
2.A Case of Acute Renal Failure, Acute Pancreatitis and Delayed Recovery of Bone Marrow Suppression, Accompanied with Ethylene Glycol Intoxication.
Seung Up KIM ; Dong Hyung LEE ; Sung Jin MOON ; Yong Sung SEO ; Jin Seok KIM ; Shin Wook KANG ; Kyu Hun CHOI ; Ho Yung LEE ; Dae Suk HAN ; Beom Seok KIM
Korean Journal of Nephrology 2006;25(1):159-163
Ethylene glycol is commonly found in automobile antifreeze and a variety of other commercial products. Ingestion of ethylene glycol, either accidentally or in a making an attempt at suicide, is characterized by severe metabolic acidosis, calcium oxalate crystal formation and deposition, and various end organ damages that may be fatal with about 80% mortality rate. We present here a case of a patient who ingested about 300cc of ethylene glycol to siucide, and developed acute renal failure, acute pancreatitis and bone marrow suppression, but successfully be treated with minimal sequelae.
Acidosis
;
Acute Kidney Injury*
;
Automobiles
;
Bone Marrow*
;
Calcium Oxalate
;
Eating
;
Ethylene Glycol*
;
Humans
;
Mortality
;
Pancreatitis*
;
Suicide
3.Extracorporeal Shockwave Therapy Alleviates Inflammatory Pain by Down-Regulating NLRP3Inflammasome in Experimental Chronic Prostatitis and Chronic Pelvic Pain Syndrome
Woong Jin BAE ; Dongho SHIN ; Jun Jie PIAO ; Soomin KIM ; Yong Sun CHOI ; Bong Hee PARK ; Hyun Jin JUNG ; Samuel SORKHI ; Saager CHAWLA ; Chung Woon CHEON ; Dae Up KANG ; Jong Tae CHOI ; Sang-Hyuck PARK ; Sae Woong KIM ; Mahadevan Raj RAJASEKARAN
The World Journal of Men's Health 2024;42(1):157-167
Purpose:
To evaluate the anti-inflammatory and antioxidative effects of extracorporeal shockwave therapy (ESWT) on prostatitis and explore the mechanism of alleviating pain.
Materials and Methods:
For in vitro testing, RWPE-1 cells were randomly divided into 5 groups: (1) RWPE-1 group (normal control), (2) LPS group (lipopolysaccharide inducing inflammation), (3) 0.1ESWT group (treated by 0.1 mJ/mm2 energy level), (4) 0.2ESWT group (treated by 0.2 mJ/mm2 energy level), and (5) 0.3ESWT group (treated by 0.3 mJ/mm2 energy level). After ESWT was administered, cells and supernatant were collected for ELISA and western blot. For in vivo testing, Sprague-Dawley male rats were randomly divided into 3 groups: (1) normal group, (2) prostatitis group, and (3) ESWT group (n=12 for each). Prostatitis was induced by 17 beta-estradiol and dihydrotestosterone (DHT) administration. Four weeks after ESWT, the pain index was assessed for all groups and prostate tissues were collected for immunohistochemistry, immunofluorescence, apoptosis analysis and, western blot.
Results:
Our in vitro studies showed that the optimal energy flux density of ESWT was 0.2 mJ/mm2. In vivo, ESWT ameliorated discomfort in rats with prostatitis and inflammation symptoms were improved. Compared to normal rats, overexpressed NLRP3 inflammasomes triggered apoptosis in rats with prostatitis and this was improved by ESWT. TLR4-NFκB pathway was overactive after experimental prostatitis, compared to normal and ESWT groups, and prostatitis induced alterations in BAX/BAK pathway were inhibited by ESWT.
Conclusions
ESWT improved CP/CPPS by reducing NLRP3 inflammasome and ameliorated apoptosis via inhibiting BAX/BAK pathway in a rat model. TLR4 may play a key role in bonding NLRP3 inflammasome and BAX/BAK pathways. ESWT might be a promising approach for the treatment of CP/CPPS.
4.KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease
Seong Hee KANG ; Hye Won LEE ; Jeong-Ju YOO ; Yuri CHO ; Seung Up KIM ; Tae Hee LEE ; Byoung Kuk JANG ; Sang Gyune KIM ; Sang Bong AHN ; Haeryoung KIM ; Dae Won JUN ; Joon-Il CHOI ; Do Seon SONG ; Won KIM ; Soung Won JEONG ; Moon Young KIM ; Hong KOH ; Sujin JEONG ; Jin-Woo LEE ; Yong Kyun CHO ;
Clinical and Molecular Hepatology 2021;27(3):363-401
5.KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease
Seong Hee KANG ; Hye Won LEE ; Jeong-Ju YOO ; Yuri CHO ; Seung Up KIM ; Tae Hee LEE ; Byoung Kuk JANG ; Sang Gyune KIM ; Sang Bong AHN ; Haeryoung KIM ; Dae Won JUN ; Joon-Il CHOI ; Do Seon SONG ; Won KIM ; Soung Won JEONG ; Moon Young KIM ; Hong KOH ; Sujin JEONG ; Jin-Woo LEE ; Yong Kyun CHO ;
Clinical and Molecular Hepatology 2021;27(3):363-401